Ritodrine Hydrochloride Synthesis for Stable Polymorph Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing Ritodrine hydrochloride result in unstable and hygroscopic polymorphic forms, affecting its stability, solubility, and bioavailability, with existing processes offering low yield and purity.
Innovation Solution
A new synthesis process involving the reaction of 4-(2-bromopropionyl)phenyl methanesulfonate with benzyl-[2-(4-benzyloxyphenyl)-ethyl]-amine, followed by hydrolysis, salification, and catalytic hydrogenation, specifically targeting the formation of non-hygroscopic and stable Ritodrine hydrochloride Form I through controlled precipitation and drying methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional synthesis methods are used to prepare Ritodrine hydrochloride, then the product can be obtained, but it exists in unstable and hygroscopic polymorphic forms with poor stability and bioavailability
Solution Approach 1:
The patent applies parameter changes by carefully controlling crystallization conditions including solvent selection (alcoholic solvents like methanol, ethanol, isopropanol), temperature ranges (0-25°C), and pH conditions during synthesis. These parameter optimizations enable consistent formation of the stable polymorphic Form I, resolving the contradiction between product stability and manufacturing control difficulty
Solution Approach 2:
The patent utilizes phase transitions during the crystallization process to obtain stable polymorphic Form I. By controlling the phase transition from solution to solid state through controlled cooling and solvent evaporation, the patent ensures formation of the thermodynamically stable form rather than metastable forms, thereby improving reliability while maintaining ease of manufacture
2Productivity
If existing synthesis processes are used, then Ritodrine hydrochloride can be produced, but with low yield and purity
Solution Approach 1:
The patent applies preliminary action by performing protective group chemistry and diastereoselective reduction steps before final product formation. The use of protecting groups during intermediate steps prevents unwanted side reactions, ensuring high purity of the final product and reducing material loss through minimized need for purification steps
Solution Approach 2:
The patent employs intermediary compounds with specific protecting groups that facilitate selective reactions. These intermediaries enable stepwise synthesis with high selectivity, improving both yield and purity while reducing material loss by preventing formation of unwanted byproducts that would require extensive purification
3Ease of operation
If non-controlled crystallization is performed, then Ritodrine hydrochloride can be obtained, but as hygroscopic Form II with poor chemical-physical properties
Solution Approach 1:
The patent applies parameter changes by optimizing crystallization conditions including using specific alcoholic solvents, controlling temperature (0-25°C), and adjusting pH to obtain stable polymorphic Form I. These controlled parameters transform the simple isolation process into a controlled crystallization that yields the stable form, resolving the contradiction between operational simplicity and product stability
Solution Approach 2:
The patent utilizes controlled phase transitions during crystallization to obtain stable polymorphic Form I. By controlling the rate of solvent evaporation and cooling, the patent ensures formation of the thermodynamically stable form with non-hygroscopic properties, maintaining ease of operation while improving stability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high yield and purity of Ritodrine hydrochloride Form I, which is non-hygroscopic and stable, enhancing its chemical-physical properties and bioavailability, while avoiding the stability and humidity-related issues associated with Form II.
Implementation Method 1
the catalytic hydrogenation of 2-{Benzyl-[2-(4-benzyloxyphenyl)-ethyl]-amino}-1-(4-hydroxy-phenyl)-propan-1-one hydrochloride (D) so as to obtain Ritodrine hydrochloride (A)
Implementation Method 2
treating Ritodrine hydrochloride in alcoholic solvent with one or more organic solvents and subsequent precipitation of Ritodrine hydrochloride Form I
Implementation Method 3
the hydrolysis of the product obtained in (a) in the corresponding deprotected form
Data Source
AI summary
The present invention describes a new method for preparing Ritodrinehydrochloride.The invention also concerns non-hygroscopic crystalline polymorphic Ritodrine hydrochloride Form (I).